The global retinal disorder treatment market size is expected to reach USD 15.8 billion by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 7.6% over the forecast period. Increasing prevalence and incidence of retinal disorders is considered to be the primary growth driver.
According
to data published in the NCBI in 2018, around 18.0% of diabetic patients in
India suffer from diabetic retinopathy. Similarly, National Eye Institute
estimates that by 2030 and 2050, around 10 and 14 million people respectively
will suffer from diabetic retinopathy in America. Based on an article published
by WebMD in 2019, age-related macular degeneration (AMD) is the leading cause
of irreversible visual loss in U.S., occurring in more than 10% of the
population aged 65-74 years. Moreover, the NCBI estimates that by 2040,
individuals with early and late AMD will range between 14.9-21.5 million and
3.9-4.8 million respectively in Europe.
Increasing
geriatric population is also anticipated to be a major factor governing the
overall market. According to data published in the World Population Prospects:
2019 Revision, around 1 in 11 and 1 in 4 people living in North America and
Europe, respectively, will be aged 65 years and above by 2050.
Growing
awareness of retinal disorders is also expected to propel market growth over
the forecast period. For instance, the Institut de la Mácula started an
awareness campaign on age-related macular degeneration in 2019. The primary aim
of this campaign is to create awareness about the disease, benefits of early
detection, and available treatment options in the market.
Full Research Report On Retinal Disorder Treatment Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/retinal-disorder-treatment-market
Further key
findings from the report suggest:
- By type,
macular degeneration held the dominant share in 2018 and is estimated to
be the fastest growing segment over the forecast period. Rising prevalence
of macular degeneration globally is the major factor driving the segment
- In 2018, dry
macular degeneration emerged as the largest segment and is expected to
register the highest CAGR through 2026
- On the basis
of dosage form, eye solutions formed the leading segment in 2018. Eye
drops are estimated to be the fastest growing segment over the forecast
period owing to strong presence of pipeline products
- Based on
distribution channel, hospital pharmacies held the largest share in 2018
while online pharmacy will exhibit the fastest growth by 2026
- North America
held the dominant revenue share in 2018 owing to presence of key players
in the market. Asia Pacific is estimated to witness the fastest CAGR of
9.5% from 2019 to 2026
- Research and
development and collaborations are some of the crucial strategies adopted
by players in the market.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/retinal-disorder-treatment-market/request/rs1
Grand View Research has
segmented the global retinal disorder treatment market based on type, dosage
form, distribution channel, and region:
Retinal Disorder
Treatment Type Outlook (Revenue, USD Million, 2014 - 2026)
- Macular Degeneration
- Dry Macular Degeneration
- Wet Macular Degeneration
- Diabetic Retinopathy
- Others
Retinal Disorder
Treatment Dosage Form Outlook (Revenue, USD Million, 2014 - 2026)
- Gels
- Eye Solutions
- Capsules & Tablets
- Eye Drops
- Ointments
Retinal Disorder
Treatment Distribution Channel Outlook (Revenue, USD Million, 2014 - 2026)
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Retinal Disorder
Treatment Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Singapore
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com